» Articles » PMID: 18388112

Triclosan Resistance in Salmonella Enterica Serovar Typhimurium

Overview
Date 2008 Apr 5
PMID 18388112
Citations 40
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: The aim of this study was to characterize the mechanisms of resistance to triclosan in Salmonella enterica serovar Typhimurium.

Methods: Mutants resistant to triclosan were selected from nine S. enterica serovar Typhimurium strains. Mutants were characterized by genotyping, mutagenesis and complementation of fabI and analysis of efflux activity. Fitness of triclosan-resistant mutants was determined in vitro and in vivo.

Results: Three distinct resistance phenotypes were observed: low- (LoT), medium- (MeT) and high-level (HiT) with MICs of 4-8, 16-32 and >32 mg/L of triclosan, respectively, for inhibition. The genotype of fabI did not correlate with triclosan MIC. Artificial overexpression and mutagenesis of fabI in SL1344 each resulted in low-level triclosan resistance, indicating that FabI alone does not mediate high-level triclosan resistance in Salmonella Typhimurium. Active efflux of triclosan via AcrAB-TolC confers intrinsic resistance to triclosan as inactivation of acrB and tolC in wild-type strains and the triclosan-resistant mutants led to large decreases in triclosan resistance, which were reversed by complementation. Exemplars of each phenotype were evaluated for fitness in vivo; no fitness cost was seen and mutants colonized and persisted in chickens throughout a 28 day competitive index experiment.

Conclusions: These data show that triclosan resistance can occur via distinct pathways in salmonella and that mutants selected after single exposure to triclosan are fit enough to compete with wild-type strains.

Citing Articles

Evolution of triclosan resistance modulates bacterial permissiveness to multidrug resistance plasmids and phages.

Yang Q, Ma X, Li M, Zhao M, Zeng L, He M Nat Commun. 2024; 15(1):3654.

PMID: 38688912 PMC: 11061290. DOI: 10.1038/s41467-024-48006-9.


Extending the Potency and Lifespan of Antibiotics: Inhibitors of Gram-Negative Bacterial Efflux Pumps.

Duffey M, Jumde R, da Costa R, Ropponen H, Blasco B, Piddock L ACS Infect Dis. 2024; 10(5):1458-1482.

PMID: 38661541 PMC: 11091901. DOI: 10.1021/acsinfecdis.4c00091.


Clinical and microbiological characterization of Salmonella spp. isolates from patients treated in a university hospital in South America between 2012-2021: a cohort study.

Rosso F, Rebellon-Sanchez D, Llanos-Torres J, Hurtado-Bermudez L, Ayerbe L, Suarez J BMC Infect Dis. 2023; 23(1):625.

PMID: 37749501 PMC: 10519077. DOI: 10.1186/s12879-023-08589-y.


Chlorhexidine Resistance or Cross-Resistance, That Is the Question.

Abbood H, Hijazi K, Gould I Antibiotics (Basel). 2023; 12(5).

PMID: 37237701 PMC: 10215778. DOI: 10.3390/antibiotics12050798.


Comparison of Phenotype and Genotype Virulence and Antimicrobial Factors of Typhimurium Isolated from Human Milk.

Plawinska-Czarnak J, Wodz K, Guzowska M, Rosiak E, Nowak T, Strzalkowska Z Int J Mol Sci. 2023; 24(6).

PMID: 36982209 PMC: 10048834. DOI: 10.3390/ijms24065135.